SPONSOR
Liaoning Cancer Hospital & Institute
Total Trials
2
Recruiting
2
Phases
Phase 2
Liaoning Cancer Hospital & Institute is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Breast Cancer Females, Non-small Cell Lung Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Liaoning Cancer Hospital & Institute
How many clinical trials has Liaoning Cancer Hospital & Institute sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Liaoning Cancer Hospital & Institute, of which 2 are actively recruiting participants. These trials cover conditions including Breast Cancer Females, Non-small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Liaoning Cancer Hospital & Institute research focus on?
Liaoning Cancer Hospital & Institute clinical trials span Breast Cancer Females, Non-small Cell Lung Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Liaoning Cancer Hospital & Institute clinical trial?
To participate in a Liaoning Cancer Hospital & Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Liaoning Cancer Hospital & Institute trials with current recruitment status updated daily.
Clinical Trials by Liaoning Cancer Hospital & Institute
NCT07657130 Phase 2
Recruiting
Optimal Application Timing of ADC Drugs for Advanced Breast Cancer
Breast Cancer Females
NCT06109454
Recruiting
Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery
Non-small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology